Kodiak’s KSI-301 Has Narrower Path Forward After Phase II/III Failure In Wet AMD

Eye
Kodiak announced results of its Phase IIb/III DAZZLE study in wet AMD • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Sensory

More from Therapy Areas